Bevacizumab- plus Olaparib-Erhaltungstherapie beim BRCA-mutierten Ovarialkarzinom

Article Properties
Refrences
Title Journal Journal Categories Citations Publication Date
Association of location of BRCA1 and BRCA2 mutations with benefit from olaparib and bevacizumab maintenance in high-grade ovarian cancer: phase III PAOLA-1/ENGOT-ov25 trial subgroup exploratory analysis Annals of Oncology
  • Medicine: Medicine (General)
  • Medicine: Internal medicine: Neoplasms. Tumors. Oncology. Including cancer and carcinogens
18 2023
Refrences Analysis
Refrences used by this article by year